Skyrizi 150 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FWYQB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $46,796
Award facts
- Contract value 100% obligated
- $46,795.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $46,795.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml syringes, with performance in Conshohocken, Pennsylvania and completion targeted for July 15, 2025. This non-set-aside award was competitively granted on July 14, 2025, leveraging AmerisourceBergen's established capabilities as a primary pharmaceutical distributor for federal medical procurement. SKYRIZI is a biologic immunosuppressant medication used to treat inflammatory skin conditions, representing the type of specialized pharmaceutical commodity that the Defense Logistics Agency procures to support military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vehicle running through December 2026 that provides comprehensive global pharmaceutical support. As a child contract under this IDC, the current award exemplifies the company's role as a critical vendor supplying brand-name medications, generics, vaccines, and specialized medical supplies across multiple therapeutic domains to support Defense Health Agency programs and other government healthcare systems worldwide. AmerisourceBergen's selection reflects its competitive standing among potential vendors within the DLA's broader pharmaceutical supply chain modernization efforts.
Quick answers
Who was awarded contract SPE2DB25FWYQB?
SPE2DB25FWYQB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 14, 2025.
How much is contract SPE2DB25FWYQB worth?
The government has obligated $46,796 on SPE2DB25FWYQB.
Is contract SPE2DB25FWYQB an order under another contract?
Yes. SPE2DB25FWYQB is a delivery order under SPE2DB25D3012, an indefinite delivery contract.
Was contract SPE2DB25FWYQB competed?
The extent of competition for SPE2DB25FWYQB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award